This retrospective cohort study provides important real-world insights into the safety of DTG-based antiretroviral regimens among Thai PLHIV. Over half of the cohort (53.86%) experienced at least one ADE within the first year of DTG therapy. This…
Prevalence and risk factors of adverse drug events with dolutegravir-based regimens among Thai people living with HIV: a retrospective cohort study | AIDS Research and Therapy
